The world’s busiest derivatives exchange is moving toward a public listing. India’s National Stock Exchange filed its draft red herring prospectus with the Securities and Exchange Board of India, targeting approximately $3.5 billion in proceeds.
This offering is structured exclusively as an offer-for-sale. The exchange will not receive fresh capital. Instead, existing shareholders are set to realize significant liquidity, with the top ten selling investors positioned to gain roughly $2.6 billion based on original acquisition costs.
Major beneficiaries include State Bank of India, which could book gains near $498 million. Billionaires Azim Premji and Radhakishan Damani also stand to profit substantially from holdings valued at over $1 billion. Conversely, Life Insurance Corporation of India retains its 10.7% stake, signaling continued confidence in the exchange’s long-term valuation.
The NSE serves over 129 million registered investors and dominates Indian trading volume. This listing follows a decade of regulatory delays stemming from co-location controversies. SEBI granted the necessary no-objection certificate in early 2026, clearing the path for this landmark debut.
Market participants should note the implications of the offer-for-sale structure. Proceeds will not fund technology or expansion. Retail investors must now assess whether the current $53 billion valuation offers sufficient upside compared to early backers. The listing also invites direct performance comparisons with the publicly traded Bombay Stock Exchange.